Price and Treatment Decisions in Epidemics: A Differential Game Approach

We consider a pharmaceutical company that sells a drug that is useful in the treatment of an infectious disease. A public authority buys the drug to heal at least a portion of the infected population. The authority has an overall budget for all health care costs in the country and can only allocate...

Full description

Bibliographic Details
Main Author: Andrea Di Liddo
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:Mathematics
Subjects:
Online Access:http://www.mdpi.com/2227-7390/6/10/190
id doaj-7a634a8df083497db953e21bbed3f717
record_format Article
spelling doaj-7a634a8df083497db953e21bbed3f7172020-11-24T21:46:26ZengMDPI AGMathematics2227-73902018-10-0161019010.3390/math6100190math6100190Price and Treatment Decisions in Epidemics: A Differential Game ApproachAndrea Di Liddo0Department of Economics, University of Foggia, Largo Papa Giovanni Paolo II, 71121 Foggia, ItalyWe consider a pharmaceutical company that sells a drug that is useful in the treatment of an infectious disease. A public authority buys the drug to heal at least a portion of the infected population. The authority has an overall budget for all health care costs in the country and can only allocate a (small) part of the budget to the purchase of the drug. The government chooses the amount of drug to be purchased in order to minimize both the number of infectious people and the perceived cost of the operation along a given time horizon. This cost can be modeled through a linear or quadratic function of the monetary cost (as generally happens in the literature) or through a specific function (blow-up) that makes the budget constraint endogenous. The pharmaceutical company chooses the price of the drug in order to maximize its profit and knowing the budget constraints of the buyer. The resulting differential game is studied by supposing the simplest possible dynamics for the population. Two different games are proposed and their solutions are discussed: a cooperative game in which the two players bargain for the price of the drug and the quantity is purchased with the aim of maximizing the overall payoff and a competitive game in which the seller announces a price strategy to the buyer and binds to it; the buyer reacts by choosing the quantity to be purchased. In the case of linear or quadratic costs, the solution provided (for budget levels is not high enough) that the government spends the entire budget to purchase the drug. This drawback does not occur when the blow-up cost function is used.http://www.mdpi.com/2227-7390/6/10/190differential gamesepidemicscost functionsStackelberg gamebargaining
collection DOAJ
language English
format Article
sources DOAJ
author Andrea Di Liddo
spellingShingle Andrea Di Liddo
Price and Treatment Decisions in Epidemics: A Differential Game Approach
Mathematics
differential games
epidemics
cost functions
Stackelberg game
bargaining
author_facet Andrea Di Liddo
author_sort Andrea Di Liddo
title Price and Treatment Decisions in Epidemics: A Differential Game Approach
title_short Price and Treatment Decisions in Epidemics: A Differential Game Approach
title_full Price and Treatment Decisions in Epidemics: A Differential Game Approach
title_fullStr Price and Treatment Decisions in Epidemics: A Differential Game Approach
title_full_unstemmed Price and Treatment Decisions in Epidemics: A Differential Game Approach
title_sort price and treatment decisions in epidemics: a differential game approach
publisher MDPI AG
series Mathematics
issn 2227-7390
publishDate 2018-10-01
description We consider a pharmaceutical company that sells a drug that is useful in the treatment of an infectious disease. A public authority buys the drug to heal at least a portion of the infected population. The authority has an overall budget for all health care costs in the country and can only allocate a (small) part of the budget to the purchase of the drug. The government chooses the amount of drug to be purchased in order to minimize both the number of infectious people and the perceived cost of the operation along a given time horizon. This cost can be modeled through a linear or quadratic function of the monetary cost (as generally happens in the literature) or through a specific function (blow-up) that makes the budget constraint endogenous. The pharmaceutical company chooses the price of the drug in order to maximize its profit and knowing the budget constraints of the buyer. The resulting differential game is studied by supposing the simplest possible dynamics for the population. Two different games are proposed and their solutions are discussed: a cooperative game in which the two players bargain for the price of the drug and the quantity is purchased with the aim of maximizing the overall payoff and a competitive game in which the seller announces a price strategy to the buyer and binds to it; the buyer reacts by choosing the quantity to be purchased. In the case of linear or quadratic costs, the solution provided (for budget levels is not high enough) that the government spends the entire budget to purchase the drug. This drawback does not occur when the blow-up cost function is used.
topic differential games
epidemics
cost functions
Stackelberg game
bargaining
url http://www.mdpi.com/2227-7390/6/10/190
work_keys_str_mv AT andreadiliddo priceandtreatmentdecisionsinepidemicsadifferentialgameapproach
_version_ 1725902141917233152